← Back to headlines
Takeda Found Guilty in US Antitrust Scheme Over Constipation Drug
A U.S. jury has found Takeda Pharmaceuticals guilty of an antitrust 'pay-for-delay' scheme, determining the company unlawfully delayed the market entry of a generic version of its constipation drug, Amitiza. This verdict comes after allegations of anti-competitive practices.
18 May, 20:57 — 19 May, 03:26
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
japan-times
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 2 regions9/34
Japan1US1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
japan-timesMostly Factual82d ago
Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury
The verdict is the first time a jury has found a pharmaceutical company liable in class-action litigation over what is called a "pay-for-delay" agreement with generic rivals.
Read full article →seeking-alphaMixed82d ago
Takeda found guilty in 'pay-for-delay' scheme over Amitiza
Read full article →Coverage Timeline
First report: seeking-alpha · 18 May, 20:57|Full coverage: 2 · 6h|Window: 6h
Left-leaningCenterRight-leaning
